https://www.selleckchem.com/pr....oducts/Sapogenins-gl
This study provided new possibilities for the development of therapeutic interventions for diabetic cardiomyopathy. There is no gold standard criterion for the diagnosis of cystic fibrosis-related liver disease (CFRLD) and there is uncertainty over its impact on the outcome of lung transplantation. Lung recipients (n=238) were divided into two groups-CFRLD and non-CFRLD based on a modified aspartate aminotransferase-to-platelet ratio index (APRI) score (mAPRI) to diagnose CFRLD and predict severity of liver disease. Groups
Like
Comment
Share
